KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Approved in Japan for Radically Unresectable or Metastatic Renal Cell Carcinoma Read more
Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID Read more
Actym Therapeutics and Wacker Biotech Sign Manufacturing Contract for Actym’s Lead Candidate for the Treatment of Solid Tumors Read more
Medicago and GSK announce the approval by Health Canada of COVIFENZ, an adjuvanted plant-based COVID-19 vaccine Read more
FDA approves Jardiance (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Read more